New Study Estimates Daily Illicit Fentanyl Use Equivalent to Nearly 9,000 mg of Morphine

Naomi Carr
Hailey Okamoto
Written by Naomi Carr on 18 August 2026
Medically reviewed by Hailey Okamoto on 20 August 2026

A new study has investigated the purity and quantity of fentanyl consumed each day by individuals in Los Angeles. By comparing these figures to standard doses of morphine and hospital dosing, the study highlights unprecedented dangers in the supply and use of street fentanyl, including exceptional levels of tolerance, indicating critical implications for treatment protocols.

New Study Estimates Daily Illicit Fentanyl Use Equivalent to Nearly 9,000 mg of Morphine

What the study found

The study’s core finding was that people who use illicit fentanyl regularly are administering daily doses that are hundreds of times more than a standard prescribed dose of typical opioids, equivalent to, on average, 8887 morphine milligrams.

The study (Godvin et al, 2026), published in Drug and Alcohol Dependence, assessed the purity of over 500 fentanyl samples and the consumption methods and amounts of 47 people who regularly use fentanyl.

Findings of this study include:

  • Among the fentanyl samples analyzed in this Los Angeles-based study, the average fentanyl concentration was 12.5%. The average daily dose of fentanyl was 1.07g, which contains 120mg of pure fentanyl
  • The average morphine milligram equivalent (MME) was 8888. This exposure was several orders of magnitude higher than opioid doses typically administered in clinical settings.

What does “morphine milligram equivalent” (MME) mean?

Morphine milligram equivalent (MME) is a standardized measuring tool that compares different types of opioids. It uses the potency of morphine as the baseline and compares other opioid potencies against this.

The MME was designed to safely compare a standard dose of morphine with a comparable opioid, such as hydrocodone or oxycodone, to enable safe and effective treatment transitions. If morphine is 1 on the MME, hydrocodone is 1, oxycodone is 1.5, and fentanyl is over 100. This huge difference means that even minuscule changes in the weight of fentanyl can significantly impact the MME comparison.

For context, in a hospital setting, fentanyl is usually administered in microgram (mcg) doses, such as 100 mcg, which is 0.1 mg. Morphine might be administered at around 2.5 to 5 mg intravenously. As such, this highlights the intricate precision required to safely administer fentanyl, in comparison to other prescription drugs.

Illicitly produced fentanyl is very commonly found in the drug supply, which varies significantly in its content, purity, and consistency.

How researchers made the estimate

The researchers ran one million bootstrap simulations, which encompassed a range of fentanyl purities based on self-reported data, recognizing the fluctuations in fentanyl purity and content, along with other variables. The large-scale simulation then accounts for these variable figures to determine an MME figure.

Limitations of the study and estimate method include:

  • Relying on self-reported data, which is not always accurate.
  • Using proxy data for drug purity figures, which might over- or underestimate the purity and could miss data, such as from batches with much higher purities.
  • Self-reported data was gathered from only 47 participants, which isn’t a large sample and may not be generalizable outside of the LA area.

However, despite these limitations, the findings of this study still highlight the extreme amounts of fentanyl being used and the high tolerance levels developed in these individuals. This is crucial information for researchers and professionals involved in the development and implementation of OUD treatments.

Why fentanyl tolerance gets so high

If someone develops fentanyl tolerance, this means that the effect of the drug has a lower impact the more they use it. For example, someone who has never taken opioids may experience a fatal overdose from a 2 mg dose of fentanyl. For someone who has developed a tolerance over many months or years of use, this dose might be ineffectual.

A very small amount of fentanyl can cause fatal respiratory depression in someone without opioid tolerance, although there is no universal lethal dose because individual risk varies substantially.

Fentanyl has a potent effect on the brain’s opioid receptors. When it binds to the receptors so intensely, the receptors adapt quickly by downregulating to protect the body. People who are dependent on fentanyl are likely to use increasing doses as their tolerance develops, in an attempt to experience the same level of effects.

Researchers in this study found that the participants in their study were using around 120 mg per day, 60 times more than a fatal dose for an opioid-naïve individual. As fentanyl is incredibly potent, slight increases in dosage can rapidly increase the level of dependence and tolerance over a short period, while significantly increasing the risk of overdose.

What this means for addiction treatment

Addiction treatment is developed through research and evidence-based approaches. For instance, opioid use disorder (OUD) treatment has been carefully researched, and there are three evidence-based, approved medications: methadone, buprenorphine, and naltrexone. These medications have been rigorously trialed and studied and proven to be effective against opioids such as heroin and prescription analgesics.

However, this study highlights issues with current treatment approaches that will need to be addressed to effectively manage the full spectrum of opioid dependence that encompasses these levels of fentanyl use. The high levels of opioid tolerance observed in this population create challenges for treatment. However, medications for OUD like methadone and buprenorphine are still recommended for people with fentanyl dependence.

Because of this, people with severe fentanyl dependence report that they struggle to commence and maintain buprenorphine, as it can trigger severe and rapid precipitated withdrawal. Additionally, buprenorphine doses are often ineffective at reducing cravings in people with this level of tolerance due to its “ceiling effect”.

As such, OUD treatment approaches will require updating and refining to determine the most effective plan to support recovery within those with such high tolerance levels and prevent or manage severe withdrawal and relapse risks. This might mean utilizing significantly higher doses of medications such as methadone or changing the way buprenorphine treatment is initiated.

Implications for public health

This has significant implications for people who use opioids, including:

Similarly, this can impact future research, such as:

  • Providing a baseline for further research looking at fentanyl purity that goes beyond proxy data gathering.
  • Investigating improvements to treatment protocols for methadone and buprenorphine that can support people with high tolerance levels through withdrawal.
  • Expanding research from just fentanyl-related tolerance and harm to incorporate other common contaminants and substances that are found in the illicit drug supply, including new synthetic opioids.

Conclusion

This study demonstrates the vast increase in opioid tolerance found among people who use fentanyl, highlighting the critical limitations of current treatment protocols. Illustrating its extreme potency and the unprecedented levels of tolerance that can develop is crucial to understanding and managing the current dangers faced by many individuals.

This is hugely significant for the future of OUD treatment, revealing an urgent need to improve the management of severe fentanyl withdrawal and the stabilization of initial and maintenance OUD medications.

Resources:

  1. Godvin, M., Friedman, J.R., Molina, C.A., Koncsol, A.J., Romero, R., Juurlink, D.N., & Shover, C.L. (2026). Estimating the Daily Milligrams of Morphine Equivalent of Illicit Fentanyl Use in Los Angeles: Clinical and Epidemiological Implications. Drug and Alcohol Dependence, 285(1), 113224. Retrieved from
  2. American Association for the Advancement of Science. (2026). People Who Use Illicit Fentanyl Consume Daily Doses Equivalent to Nearly 9,000 Milligrams of Morphine. EurekAlert! Retrieved from
  3. Adams, M.C.B., Sward, K.A., Perkins, M.L., & Hurley, R.W. (2025). Standardizing Research Methods for Opioid Dose Comparison: The NIH HEAL Morphine Milligram Equivalent Calculator. Pain, 166(8), 1729–1737. Retrieved from
  4. Han, Y., Yan, W., Zheng, Y., Khan, M.Z., Yuan, K., & Lu, L. (2019). The Rising Crisis of Illicit Fentanyl Use, Overdose, and Potential Therapeutic Strategies. Translational Psychiatry, 9(1), 282. Retrieved from
  5. Shearer, D., Young, S., Fairbairn, N., & Brar, R. (2022). Challenges with Buprenorphine Inductions in the Context of the Fentanyl Overdose Crisis: A Case Series. Drug and Alcohol Review, 41(2), 444–448. Retrieved from
  6. Antoine, D., Huhn, A.S., Strain, E.C., Turner, G., Jardot, J., Hammond, A.S., & Dunn, K.E. (2021). Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone. The American Journal on Addictions, 30(1), 83–87. Retrieved from

Activity History - Last updated: 20 August 2026, Published date:


Reviewer

Hailey Okamoto

M.Ed, LCMHCS, LCAS, CCS

Hailey Okamoto is a Licensed Clinical Mental Health Counselor, Licensed Clinical Addiction Specialist, and Certified Clinical Supervisor with extensive experience in counseling people with mental health and addictive disorders.

Activity History - Medically Reviewed on 18 August 2026 and last checked on 20 August 2026

Medically reviewed by
Hailey Okamoto

Hailey Okamoto

M.Ed, LCMHCS, LCAS, CCS

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org